Gemmer Asset Management’s Exact Sciences EXAS Stock Holding History

Gemmer Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1	Closed	–	–	1367
2019 Q3	$0	Buy	+1	New	+$114	﹤0.01%	1410

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Gemmer Asset Management's EXAS Position: Q4 2019 in Review

Gemmer Asset Management sold out of Exact Sciences (EXAS) in Q4 2019, closing a stake of 1 share.

Gemmer Asset Management first reported a position in EXAS in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 527 funds tracked by Wall St. Rank hold EXAS as of Q4 2019.

Gemmer Asset Management reported no remaining Exact Sciences position as of Q4 2019 after selling out during the quarter.
Gemmer Asset Management sold 1 Exact Sciences share in Q4 2019.
Gemmer Asset Management first reported a position in Exact Sciences in Q3 2019 and held it in 1 quarter.
Gemmer Asset Management's Exact Sciences position peaked at $0 in Q3 2019.
527 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2019.

Based on Gemmer Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.